Clinical Trials in Washington

Showing 1841-1860 of 4,564 trials

FreeStyle Libre 3 Continuous Glucose Monitoring System

NCT05962710

The purpose of this study is to characterize the FreeStyle Libre 3 Continuous Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.

Diabetes Mellitus

Abbott Diabetes Care7 participantsStarted Jan 2023

Santa Barbara, California, United States • Idaho Falls, Idaho, United States • San Antonio, Texas, United States +1 more locations

TERMINATEDPhase 439 miles

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

NCT05119439

This study seeks to evaluate the efficacy, side effect profile and acceptability of a medical abortion regimen with mifepristone and two doses of 800 mcg misoprostol buccally at 71-77 and 78-84 days of gestation to further expand the evidence base for the most effective regimens in the late first trimester of pregnancy.

Medical Abortion

Gynuity Health Projects23 participantsStarted Oct 2022

Hilo, Hawaii, United States • Honolulu, Hawaii, United States • Saint Paul, Minnesota, United States +3 more locations

COMPLETEDPhase 242 miles

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

NCT00258388

RATIONALE: Drugs used in chemotherapy, such as docetaxel and prednisone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. OGX-011 may help docetaxel and prednisone kill more tumor cells by making tumor cells less resistant to the drugs. PURPOSE: This randomized phase II trial is studying how well giving docetaxel and prednisone with or without OGX-011 works in treating patients with recurrent or metastatic prostate cancer that did not respond to previous hormone therapy.

Prostate Cancer

NCIC Clinical Trials Group82 participantsStarted Sep 2005

Seattle, Washington, United States • Calgary, Canada • Edmonton, Canada +10 more locations

FreeStyle Libre 3 Continuous Glucose Monitoring System

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Find Trials by Condition in Washington

Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer

Look AHEAD: Action for Health in Diabetes

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

ImmuneSense™ COVID-19 Cross-Reactivity Study

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Bortezomib in Treating Patients With Mantle Cell Lymphoma

Family Health History in Diverse Care Settings (FHH)